TrialBone2019

Comparison of risedronate versus placebo in preventing anastrozole-induced bone loss in women at high risk of developing breast cancer with osteopenia.

Ivana Sestak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.